Jaguar Health

JAGX NASDAQ
0.2130
+0.0428
+25.15%
盘后: 0.1949 -0.0181 -8.50% 19:22 05/17 EDT
开盘
0.1700
昨收
0.1702
最高
0.2175
最低
0.1650
成交量
872.50万
成交均量(3M)
784.49万
52周最高
3.200
52周最低
0.1150
换手率
8.75%
市值
2,123.96万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供Jaguar Health JAGX股票价格,Jaguar Health股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.
展开 >

最近浏览

名称
价格
涨跌幅